Evidence map›Paper›PMID 36936344›Full record

ArticleACS omega2023

Improving Flame Retardant Properties of Aliphatic Polyketone (POK)-Based Composites.

Cansu Yıldız, Yoldas Seki, Merve Ekti, Sibel Aker, Berkay Metin Leskeri, Mehmet Sarikanat, Lutfiye Altay

Full text read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cansu YıldızThe Graduate School of Natural and Applied Sciences, Dokuz Eylul University, Buca, İzmir 35390, Turkey.
Yoldas SekiFaculty of Science, Dokuz Eylul University, Buca, Izmir 35160, Turkey.ORCID https://orcid.org/0000-0002-2225-1236
Merve Ektiİzmir Eğitim Sağlık Sanayi Yatırım A.Ş., Turgutlu, Manisa 45400, Turkey.
Sibel Akerİzmir Eğitim Sağlık Sanayi Yatırım A.Ş., Turgutlu, Manisa 45400, Turkey.
Berkay Metin Leskeriİzmir Eğitim Sağlık Sanayi Yatırım A.Ş., Turgutlu, Manisa 45400, Turkey.
Mehmet SarikanatMechanical Engineering Department, Ege University, Bornova, Izmir 35040, Turkey.ORCID https://orcid.org/0000-0003-1094-2272
Lutfiye AltayMechanical Engineering Department, Ege University, Bornova, Izmir 35040, Turkey.ORCID https://orcid.org/0000-0003-4946-3615

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effect of zinc borate (ZB) and high-molecular-weight siloxane (SIL) on flame retardancy, mechanical, and thermal properties of aliphatic polyketone (POK)-containing aluminum diethyl phosphinate (OF) was investigated in this study. Ten wt % OF is sufficient to obtain V0 rating according to the UL94 test. As the weight fraction of OF was increased, the flame retardancy properties and LOI values improved, while the tensile and impact properties decreased. To avoid the degradation in mechanical and impact properties as much as possible and obtain the same and better flame retardancy properties, synergists such as SIL and ZB were used. Flame retardancy of POK-based composites was determined by the limiting oxygen index (LOI) test, UL94 measurement, and cone calorimeter test. The additions of 1 wt % SIL and ZB have not led to a considerable decrease in the tensile strength and impact properties of POK-10OF. While ZB and SIL are very efficient in decreasing the smoke density, ZB is more efficient than SIL in increasing the LOI value of the composite. The addition of 1, 2, and 4 wt % ZB and SIL synergists did not lower their UL94 ratings. Moreover, it can be added that ZB is more efficient than SIL in decreasing the fire growth rate (FIGRA) and maximum average rate of heat emission (MARHE) values. Using OF (10 wt %) and ZB (4 wt %), LOI values higher than 32% and smoke density values lower than 150 were obtained.

Identifiers

PMID36936344
PMCPMC10018683

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read45
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.